B. Mirviss Jeffrey's most recent trade in Boston Scientific Corp. was a trade of 4,675 Common Stock done at an average price of $104.3 . Disclosure was reported to the exchange on Feb. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 104.25 per share. | 24 Feb 2025 | 4,675 | 28,454 (0%) | 0% | 104.3 | 487,369 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 104.00 per share. | 24 Feb 2025 | 2,688 | 25,766 (0%) | 0% | 104 | 279,552 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 105.35 per share. | 19 Feb 2025 | 1,510 | 33,129 (0%) | 0% | 105.4 | 159,079 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 13,334 | 13,334 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,181 | 5,181 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,334 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,334 | 36,160 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,970 | 2,970 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,970 | 34,181 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,776 | 5,552 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,776 | 32,477 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,521 | 34,639 (0%) | 0% | 106.1 | 161,393 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,355 | 32,826 (0%) | 0% | 106.1 | 143,779 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,266 | 31,211 (0%) | 0% | 106.1 | 134,335 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,115 | 6,347 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,115 | 30,569 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 868 | 29,701 (0%) | 0% | 105.8 | 91,808 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 23,760 | 52,214 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 105.06 per share. | 11 Feb 2025 | 13,022 | 28,454 (0%) | 0% | 105.1 | 1,368,073 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 10,738 | 41,476 (0%) | 0% | 106.0 | 1,138,013 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 10,430 | 0 | - | - | Performance Share Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 10,430 | 38,884 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 89.86 per share. | 01 Jan 2025 | 7,152 | 28,454 (0%) | 0% | 89.9 | 642,658 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 3,278 | 35,606 (0%) | 0% | 89.3 | 292,791 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 29 May 2024 | 63,802 | 28,022 (0%) | 0% | 75.1 | 4,791,447 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 33,726 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 29 May 2024 | 33,726 | 91,824 (0%) | 0% | 17.3 | 582,111 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 66.45 per share. | 18 Mar 2024 | 14,506 | 58,098 (0%) | 0% | 66.5 | 963,930 | Common Stock |
| Boston Scientific Corp. | B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 66.35 per share. | 21 Feb 2024 | 4,960 | 72,604 (0%) | 0% | 66.4 | 329,096 | Common Stock |
| Boston Scientific Corp. | B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,333 | 77,552 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,333 | 3,334 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,970 | 75,574 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,970 | 5,940 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Mirviss B. Jeffrey | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,817 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | B. Mirviss Jeffrey | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,817 | 78,849 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,520 | 76,032 (0%) | 0% | 65.8 | 100,046 | Common Stock |
| Boston Scientific Corp. | B. Mirviss Jeffrey | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,355 | 74,219 (0%) | 0% | 65.8 | 89,186 | Common Stock |
| Boston Scientific Corp. | B. Mirviss Jeffrey | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,285 | 77,564 (0%) | 0% | 65.8 | 84,579 | Common Stock |
| Boston Scientific Corp. | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 2,776 | 8,328 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey Mirviss B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 2,776 | 73,870 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | B. Mirviss Jeffrey | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.95 per share. | 14 Feb 2024 | 1,266 | 72,604 (0%) | 0% | 66.0 | 83,493 | Common Stock |
| Boston Scientific Corp. | B. Mirviss Jeffrey | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 22,311 | 22,311 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | Jeffrey Mirviss B. | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 8,462 | 8,462 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 26,666 | 83,254 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Mirviss B. Jeffrey | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Feb 2024 | 12,160 | 71,094 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 09 Jan 2024 | 15,172 | 71,760 (0%) | 0% | 16.3 | 247,455 | Common Stock |
| Boston Scientific Corp. | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 15,172 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 59.25 per share. | 09 Jan 2024 | 15,172 | 56,588 (0%) | 0% | 59.3 | 898,941 | Common Stock |
| Boston Scientific Corp. | Jeffrey Mirviss B. | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 58.40 per share. | 04 Jan 2024 | 15,000 | 56,588 (0%) | 0% | 58.4 | 876,002 | Common Stock |
| Boston Scientific Corp. | Jeffrey Mirviss B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 04 Jan 2024 | 15,000 | 71,588 (0%) | 0% | 16.3 | 244,650 | Common Stock |
| Boston Scientific Corp. | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2024 | 15,000 | 15,172 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | Jeffrey Mirviss B. | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 57.82 per share. | 03 Jan 2024 | 11,931 | 56,588 (0%) | 0% | 57.8 | 689,862 | Common Stock |
| Boston Scientific Corp. | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 17,439 | 74,027 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 17,439 | 0 | - | - | Performance Share Units | |
| Boston Scientific Corp. | B. Mirviss Jeffrey | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.81 per share. | 01 Jan 2024 | 5,508 | 68,519 (0%) | 0% | 57.8 | 318,417 | Common Stock |
| Boston Scientific Corp. | B. Jeffrey Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 55.03 per share. | 06 Dec 2023 | 353 | 56,588 (0%) | 0% | 55.0 | 19,426 | Common Stock |
| Boston Scientific Corp. | Mirviss B. Jeffrey | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2023 | 649 | 57,237 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey Mirviss B. | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2023 | 649 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | B. Mirviss Jeffrey | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.14 per share. | 03 Dec 2023 | 296 | 56,941 (0%) | 0% | 56.1 | 16,617 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Nov 2023 | 4,000 | 56,588 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 53.14 per share. | 28 Aug 2023 | 13,971 | 65,245 (0%) | 0% | 53.1 | 742,419 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 54.50 per share. | 28 Aug 2023 | 4,657 | 60,588 (0%) | 0% | 54.5 | 253,811 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 50.40 per share. | 05 Apr 2023 | 4,903 | 78,673 (0%) | 0% | 50.4 | 247,111 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 49.60 per share. | 30 Mar 2023 | 4,903 | 83,576 (0%) | 0% | 49.6 | 243,189 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.10 per share. | 21 Feb 2023 | 3,340 | 88,479 (0%) | 0% | 46.1 | 153,974 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 2,804 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 2,804 | 95,411 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.32 per share. | 21 Feb 2023 | 2,313 | 91,819 (0%) | 0% | 46.3 | 107,138 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.23 per share. | 21 Feb 2023 | 1,279 | 94,132 (0%) | 0% | 46.2 | 59,128 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,333 | 93,873 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,333 | 6,667 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 2,970 | 8,910 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 2,970 | 92,858 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 2,817 | 93,609 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 2,817 | 2,817 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.35 per share. | 16 Feb 2023 | 2,061 | 90,792 (0%) | 0% | 46.3 | 95,527 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.79 per share. | 16 Feb 2023 | 1,409 | 90,540 (0%) | 0% | 46.8 | 65,927 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.54 per share. | 16 Feb 2023 | 1,020 | 92,853 (0%) | 0% | 46.5 | 47,471 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.54 per share. | 16 Feb 2023 | 1,002 | 92,607 (0%) | 0% | 46.5 | 46,633 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.48 per share. | 16 Feb 2023 | 909 | 91,949 (0%) | 0% | 46.5 | 42,250 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 2,031 | 90,510 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 2,031 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.29 per share. | 15 Feb 2023 | 622 | 89,888 (0%) | 0% | 47.3 | 29,414 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 28,893 | 28,893 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 11,104 | 11,104 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 10,430 | 10,430 | - | - | Performance Share Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.38 per share. | 04 Jan 2023 | 6,751 | 88,479 (0%) | 0% | 46.4 | 313,123 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 9,981 | 98,460 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 9,981 | 0 | - | - | Performance Share Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.27 per share. | 01 Jan 2023 | 3,230 | 95,230 (0%) | 0% | 46.3 | 149,452 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.75 per share. | 12 Dec 2022 | 11,080 | 88,479 (0%) | 0% | 46.8 | 517,990 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.15 per share. | 09 Dec 2022 | 41,032 | 99,559 (0%) | 0% | 46.1 | 1,893,504 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 29,599 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.08 per share. | 09 Dec 2022 | 29,599 | 140,591 (0%) | 0% | 13.1 | 387,155 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2022 | 649 | 649 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2022 | 649 | 111,288 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.60 per share. | 03 Dec 2022 | 296 | 110,992 (0%) | 0% | 46.6 | 13,794 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Dec 2022 | 230 | 110,639 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Dec 2022 | 26 | 110,290 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 46.50 per share. | 20 Apr 2022 | 9,645 | 110,316 (0%) | 0% | 46.5 | 448,493 | Common Stock |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Sale of securities on an exchange or to another person at price $ 45.50 per share. | 19 Apr 2022 | 10,989 | 119,961 (0%) | 0% | 45.5 | 500,000 | Common Stock |